Ryosaku Azemoto

630 total citations
19 papers, 281 citations indexed

About

Ryosaku Azemoto is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Ryosaku Azemoto has authored 19 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Surgery and 7 papers in Hepatology. Recurrent topics in Ryosaku Azemoto's work include Liver Disease Diagnosis and Treatment (5 papers), Gallbladder and Bile Duct Disorders (4 papers) and Hepatitis C virus research (4 papers). Ryosaku Azemoto is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Gallbladder and Bile Duct Disorders (4 papers) and Hepatitis C virus research (4 papers). Ryosaku Azemoto collaborates with scholars based in Japan. Ryosaku Azemoto's co-authors include Osamu Yokosuka, Sadahisa Ogasawara, Masao Ohto, Yoshihiko Ooka, Makoto Ogawa, Tetsuhiro Chiba, M Wakashin, Hiromichi Yoshida, Akinobu Tawada and K Iesato and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Kidney International.

In The Last Decade

Ryosaku Azemoto

18 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryosaku Azemoto Japan	10	136	110	69	65	61	19	281
Masaya Tamano Japan	10	150 1.1×	141 1.3×	98 1.4×	60 0.9×	51 0.8×	66	333
Daisuke Kakinuma Japan	11	131 1.0×	82 0.7×	167 2.4×	74 1.1×	72 1.2×	41	324
Hyun Yang South Korea	14	238 1.8×	152 1.4×	67 1.0×	31 0.5×	86 1.4×	40	398
Michele Pohlen Germany	11	84 0.6×	67 0.6×	87 1.3×	51 0.8×	61 1.0×	18	313
Kota Tsuruya Japan	13	206 1.5×	175 1.6×	99 1.4×	37 0.6×	77 1.3×	46	408
Wei‐Fan Hsu Taiwan	12	220 1.6×	193 1.8×	90 1.3×	66 1.0×	49 0.8×	45	365
Takayuki Shiraki Japan	11	124 0.9×	90 0.8×	116 1.7×	75 1.2×	145 2.4×	42	328
Takuya Hiwaki Japan	8	325 2.4×	233 2.1×	126 1.8×	98 1.5×	40 0.7×	12	413
Yuki Tsuji Japan	14	154 1.1×	198 1.8×	125 1.8×	61 0.9×	44 0.7×	43	450
Holly Cline-Fedewa United States	10	128 0.9×	104 0.9×	42 0.6×	66 1.0×	32 0.5×	16	334

Countries citing papers authored by Ryosaku Azemoto

Since Specialization

Citations

This map shows the geographic impact of Ryosaku Azemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosaku Azemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosaku Azemoto more than expected).

Fields of papers citing papers by Ryosaku Azemoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosaku Azemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosaku Azemoto. The network helps show where Ryosaku Azemoto may publish in the future.

Co-authorship network of co-authors of Ryosaku Azemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosaku Azemoto. A scholar is included among the top collaborators of Ryosaku Azemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosaku Azemoto. Ryosaku Azemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Yoshida, Yu, et al.. (2021). A case of underwater endoscopic ultrasound guided abscess drainage. Progress of Digestive Endoscopy. 99(1). 137–139. 1 indexed citations

Tsuyuguchi, Toshio, Kenji Shimura, Hideaki Mizumoto, et al.. (2020). Safety and Efficacy of Early Tube Removal Following Percutaneous Transhepatic Gallbladder Drainage: an Observational Study. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 30(2). 164–168. 9 indexed citations

Kanogawa, Naoya, Sadahisa Ogasawara, Tetsuhiro Chiba, et al.. (2015). Sustained virologic response achieved after curative treatment of hepatitis C virus‐related hepatocellular carcinoma as an independent prognostic factor. Journal of Gastroenterology and Hepatology. 30(7). 1197–1204. 30 indexed citations

Ogasawara, Sadahisa, Tetsuhiro Chiba, Yoshihiko Ooka, et al.. (2015). A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. PLoS ONE. 10(4). e0125244–e0125244. 29 indexed citations

Azemoto, Ryosaku, et al.. (2015). Suspicion of Superior Mesenteric Artery Syndrome in a Patient with Severe Gastric Dilatation after Catheter Ablation. Internal Medicine. 54(6). 605–609.

Sudo, Kentaro, Takeshi Ishihara, Nobuto Hirata, et al.. (2013). Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemotherapy and Pharmacology. 73(2). 389–396. 40 indexed citations

Kanda, Tatsuo, Fumio Imazeki, Rintaro Mikata, et al.. (2012). Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1. Hepatology International. 7(1). 144–152. 8 indexed citations

Ogasawara, Sadahisa, Fumihiko Kanai, Shuntaro Obi, et al.. (2011). Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatology International. 5(3). 850–856. 39 indexed citations

Kanda, Tatsuo, Fumio Imazeki, Ryosaku Azemoto, et al.. (2011). Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2. Digestive Diseases and Sciences. 56(11). 3335–3342. 20 indexed citations

10.

Nakamura, Kenji, Tomohiro Yamaguchi, Tadamichi Denda, et al.. (2009). A phase II trial of oral S-1 combined with gemcitabine in patients with unresectable biliary tract cancer. Journal of Clinical Oncology. 27(15_suppl). e15527–e15527. 4 indexed citations

11.

Kanda, Tatsuo, Osamu Yokosuka, Fumio Imazeki, et al.. (2007). Body mass index in Japanese patients with autoimmune liver disease: overweight patients with primary biliary cirrhosis tend to be asymptomatic.. PubMed. 54(78). 1758–60. 6 indexed citations

12.

Azemoto, Ryosaku, et al.. (2003). Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. Journal of Gastroenterology. 38(11). 1071–1076. 5 indexed citations

13.

Azemoto, Ryosaku, et al.. (1996). Does gallstone formation after open cardiac surgery result only from latent hemolysis by replaced valves?. PubMed. 91(10). 2185–9. 16 indexed citations

14.

Ogawa, Makoto, Teruo Mori, Shiro Ueda, et al.. (1992). Study on Chronic Renal Injuries Induced by Carbon Tetrachloride: Selective Inhibition of the Nephrotoxicity by Irradiation. The Nephron journals/Nephron journals. 60(1). 68–73. 31 indexed citations

15.

Ogawa, Makoto, Ryosaku Azemoto, Yuko Makino, et al.. (1991). Pneumothorax in a patient with Wegener's granulomatosis during treatment with immunosuppressive agents. Journal of Internal Medicine. 229(2). 189–192. 10 indexed citations

16.

Yoshida, Hiromichi, Shiro Ueda, Ryosaku Azemoto, et al.. (1990). Detection of nephritogenic antigen from the Lewis rat renal tubular basement membrane. Kidney International. 37(5). 1286–1294. 8 indexed citations

17.

Ogawa, Makoto, Yasukiyo Mori, Taketoshi Mori, et al.. (1988). Adoptive transfer of experimental autoimmune hepatitis in mice--cellular interaction between donor and recipient mice.. PubMed. 73(2). 276–82. 13 indexed citations

18.

Ueda, Shiro, M Wakashin, Hiromichi Yoshida, et al.. (1988). Autoimmune interstitial nephritis induced in inbred mice. Analysis of mouse tubular basement membrane antigen and genetic control of immune response to it.. PubMed. 132(2). 304–18. 6 indexed citations

19.

Ueda, Shiro, M Wakashin, Teruo Mori, et al.. (1987). Suppressor system in murine interstitial nephritis. Clinical Immunology and Immunopathology. 45(1). 78–91. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact